Showing results (241-250 of 536) with videos related to
Sort By:
Pageof 54
Journal of the American Society of Nephrology : JASN|November 26, 2003
Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptorsBishoy Rizkalla, Josephine M Forbes, Mark E Cooper, et al.Kidney International|May 24, 2013
Report on ISN Forefronts, Melbourne, Australia, 4-7 October 2012: tubulointerstitial disease in diabetic nephropathyJosephine M Forbes, David C H Harris, Mark E CooperKidney International|August 26, 2004
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetesGuorong Ma, Terri J Allen, Mark E Cooper, et al.Seminars in Nephrology|May 14, 2018
Cardiovascular Disease and Diabetic Kidney DiseaseMuhammad Maqbool, Mark E Cooper, Karin A M Jandeleit-DahmCurrent Opinion in Investigational Drugs (London, England : 2000)|October 30, 2003
Diabetes mellitus: a cardiovascular diseaseRiccardo Candido, Piyush Srivastava, Mark E Cooper, et al.Nature Reviews. Endocrinology|October 9, 2013
Diabetic nephropathy: diagnosis and treatmentDaniel Fineberg, Karin A M Jandeleit-Dahm, Mark E CooperThescientificworldjournal|June 14, 2003
Amylin in the peripheryPeter J Wookey, Loredanna Xuereb, Christos Tikellis, et al.Seminars in Nephrology|April 10, 2007
AGE, RAGE, and ROS in diabetic nephropathyAdeline L Y Tan, Josephine M Forbes, Mark E CooperCurrent Hypertension Reports|March 8, 2005
Advanced-glycation end products in insulin-resistant statesGeorgia Soldatos, Mark E Cooper, Karin A M Jandeleit-DahmDiabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 14, 2019
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment ParadigmViswanathan Mohan, Mark E Cooper, David R Matthews, et al.Pageof 54